Literature DB >> 1609545

Cytokines as immunological adjuvants.

A W Heath1, J H Playfair.   

Abstract

Various cytokines have been shown to be effective immunological adjuvants in a variety of model systems, enhancing protection induced by viral, bacterial and parasitic vaccines, and increasing parameters of immunity in tumour immunization models and in clinical trials. While in most cases cytokine adjuvanticity is not as powerful as that shown by the best experimental adjuvants, such as saponin and Freund's, it can rival that of the adjuvants presently allowed for human use and there are many possible routes to improvement. The use of cytokines may allow for a choice of which immune parameters are enhanced in order to further enhance protective effects and decrease the negative effects of vaccines.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1609545     DOI: 10.1016/0264-410x(92)90389-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Drug use in infection control--is more less?

Authors:  G S Itokazu; R A Weinstein
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

2.  Pseudotyped single-cycle simian immunodeficiency viruses expressing gamma interferon augment T-cell priming responses in vitro.

Authors:  Yue Peng; Fan-ching Lin; Paulo H Verardi; Leslie A Jones; Michael B McChesney; Tilahun D Yilma
Journal:  J Virol       Date:  2006-12-13       Impact factor: 5.103

3.  Expression of the murine interleukin-4 gene in an attenuated aroA strain of Salmonella typhimurium: persistence and immune response in BALB/c mice and susceptibility to macrophage killing.

Authors:  K Denich; P Börlin; P D O'Hanley; M Howard; A W Heath
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

Review 4.  Carbon nanotubes as vaccine scaffolds.

Authors:  David A Scheinberg; Michael R McDevitt; Tao Dao; J Justin Mulvey; Evan Feinberg; Simone Alidori
Journal:  Adv Drug Deliv Rev       Date:  2013-07-27       Impact factor: 15.470

5.  General strategy for decoration of enveloped viruses with functionally active lipid-modified cytokines.

Authors:  Hans J Kueng; Victoria M Leb; Daniela Haiderer; Graça Raposo; Clotilde Thery; Sophia V Derdak; Klaus G Schmetterer; Alina Neunkirchner; Christian Sillaber; Brian Seed; Winfried F Pickl
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

6.  Effects of DDA, CpG-ODN, and plasmid-encoded chicken IFN-gamma on protective immunity by a DNA vaccine against IBDV in chickens.

Authors:  Ha Jung Roh; Haan Woo Sung; Hyuk Moo Kwon
Journal:  J Vet Sci       Date:  2006-12       Impact factor: 1.672

Review 7.  Regulation of Effector and Memory CD8 T Cell Differentiation by IL-2-A Balancing Act.

Authors:  Vandana Kalia; Surojit Sarkar
Journal:  Front Immunol       Date:  2018-12-20       Impact factor: 7.561

8.  Interleukin-1β expression by a recombinant porcine reproductive and respiratory syndrome virus.

Authors:  Steven R Lawson; Yanhua Li; John B Patton; Robert J Langenhorst; Zhi Sun; Zhiyong Jiang; Jane Christopher-Hennings; Eric A Nelson; David Knudsen; Ying Fang; Kyeong-Ok Chang
Journal:  Virus Res       Date:  2011-11-20       Impact factor: 3.303

9.  Formulation and delivery of vaccines: Ongoing challenges for animal management.

Authors:  Sameer Sharma; Lyn A Hinds
Journal:  J Pharm Bioallied Sci       Date:  2012-10

10.  Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine.

Authors:  L Steidler; K Robinson; L Chamberlain; K M Schofield; E Remaut; R W Le Page; J M Wells
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.